Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-850-8 | CAS number: 25327-89-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1981
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- 1,1'-isopropylidenebis[4-(allyloxy)-3,5-dibromobenzene]
- EC Number:
- 246-850-8
- EC Name:
- 1,1'-isopropylidenebis[4-(allyloxy)-3,5-dibromobenzene]
- Cas Number:
- 25327-89-3
- Molecular formula:
- C21H20Br4O2
- IUPAC Name:
- 1,1'-isopropylidenebis[4-(allyloxy)-3,5-dibromobenzene]
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- The rabbits were quarantined and acclimated to laboratory conditions for 6 days prior to initiation of the study.
Animals were observed twice deny during the quarantine period. On the last day of the quaerentine period (i.e. the day prior to initiation of exposure to the test material) ten rabbits (5 males and 5 fernals) were selected from the animal shipment used for the study.
Each rabbit was sexed, weighted and ear tagged with a unique animal number and each cage bore that number.
Body weights were measured and they ranged from 2.05 to 2.45 kilograms. The rabbits were individually housed in steel wire-bottomed cages suspended above the droppings.
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- physiological saline
- Details on dermal exposure:
- Individual dose amounts were calculated using day 0 body weights. The test materiel was slightly moistened with physiological saline and applied to the test site on each rabbit from a plastic disposable weigh boat. A glass stirring rod was used to distribute the test material evenly over the exposure site (approximately 240 cm2). Just prior to the application of the test material, the skin test site on all of the animals was abraded by making a series of parallel, epidermal abrasions, every 2 or 3 centimeters longitudinally with a 25-gauge hypodermic needle. These abrasions were made sufficiently deep to penetrate the stratum corneum but not to disturb the derma or to produce bleeding.
Each test site was immediately occluded with a layer of 4-ply gauze, two single layers thick. The trunk of the rabbit was wrapped with rubber latex dental dam and the dental dam taped at the edges with 1 inch Micropore tape to form an airtight occlusive wrap. To prevent oral ingestion of the test material, each rabbit was maintained in a Newmann harness for the twenty-four hours exposure period. - Duration of exposure:
- The test material remained in contact with the skin for twenty-four hours.
- Doses:
- 2 g/kg
- No. of animals per sex per dose:
- 5 male and 5 femals
- Control animals:
- no
- Details on study design:
- All animals selected for the study were weighed at -1, 0, and 13 days.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no deaths occurred
- Clinical signs:
- other: no abnoralities were observed
- Gross pathology:
- no abnoralities were observed
- Other findings:
- Moderate to slight erythema and edema decreasing in severity and area with time.
Five/ten animals appeared normal by day 2.
Ten/ten animals appeared normal by day 7.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- LD50 > 2000 mg/kg
- Executive summary:
When BE-51 was administered dermally at a single dose of 2 g/kg to ten albino rabbits (5 males and 5 females) no signs of systemic toxicity or mortality were noted. Evaluation of local skin reactions revealed moderate to slight erythema and edema decreasing in severity and area with time. (Five/ten animals appearing normal by day 2 and the others appearing normal by day 7.) No significant gross pathologic findings were observed.
From the data presented. The LD50 of BE-51 is greater than 2000 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
